<DOC>
	<DOCNO>NCT00475735</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy investigational treatment Attention Deficit Hyperactivity Disorder ( ADHD ) compare placebo .</brief_summary>
	<brief_title>A Study Test Safety Efficacy MK0249 Patients With ADHD ( 0249-018 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Patient 18 55 year age ( inclusive ) Patient adult current DSMIV diagnosis ADHD inattentive combine subtype , assess via structure interview use ACDS AISRS Females childbearing potential must use acceptable method birth control study 1 month posttherapy Patient history neurological disorder result ongoing impairment Patient lifetime history psychotic disorder , bipolar disorder , posttraumatic stress disorder Patient evidence ongoing depression Patient sensitive allergic methylphenidate Patient glaucoma Patient previous history narrow blockage GI tract Patient history sleep disorder ( e.g. , insomnia , sleep apnea , nightmare , night terror ) within 6 month prior screen Patient history cardiovascular disorder within 6 month prior screen Patient moderate severe persistent asthma Patient history substance abuse dependence sustain full remission least one year accord DSMIV Patient take part research study within past 30 day sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>